The gut–liver axis and gut microbiota in health and liver disease

被引:0
|
作者
Cynthia L. Hsu
Bernd Schnabl
机构
[1] University of California San Diego,Department of Medicine
[2] VA San Diego Healthcare System,Department of Medicine
来源
关键词
D O I
暂无
中图分类号
学科分类号
摘要
The trillions of microorganisms in the human intestine are important regulators of health, and disruptions in the gut microbial communities can cause disease. The gut, liver and immune system have a symbiotic relationship with these microorganisms. Environmental factors, such as high-fat diets and alcohol consumption, can disrupt and alter microbial communities. This dysbiosis can lead to dysfunction of the intestinal barrier, translocation of microbial components to the liver and development or progression of liver disease. Changes in metabolites produced by gut microorganisms can also contribute to liver disease. In this Review, we discuss the importance of the gut microbiota in maintenance of health and the alterations in microbial mediators that contribute to liver disease. We present strategies for modulation of the intestinal microbiota and/or their metabolites as potential treatments for liver disease.
引用
收藏
页码:719 / 733
页数:14
相关论文
共 50 条
  • [41] The Gut Microbiota and Nonalcoholic Fatty Liver Disease
    Quigley, Eamonn M.
    Monsour, Howard P.
    [J]. SEMINARS IN LIVER DISEASE, 2015, 35 (03) : 262 - 269
  • [42] Roles of Gut Microbiota in Alcoholic Liver Disease
    Zhang, Daya
    Liu, Zhengjin
    Bai, Feihu
    [J]. INTERNATIONAL JOURNAL OF GENERAL MEDICINE, 2023, 16 : 3735 - 3746
  • [43] Gut Microbiota of Nonalcoholic Fatty Liver Disease
    Reham M. Abdou
    Lixin Zhu
    Robert D. Baker
    Susan S. Baker
    [J]. Digestive Diseases and Sciences, 2016, 61 : 1268 - 1281
  • [44] Gut Microbiota of Nonalcoholic Fatty Liver Disease
    Abdou, Reham M.
    Zhu, Lixin
    Baker, Robert D.
    Baker, Susan S.
    [J]. DIGESTIVE DISEASES AND SCIENCES, 2016, 61 (05) : 1268 - 1281
  • [45] Gut and oral microbiota in autoimmune liver disease
    Abe, Kazumichi
    Fujita, Masashi
    Hayashi, Manabu
    Okai, Ken
    Takahashi, Atsushi
    Ohira, Hiromasa
    [J]. FUKUSHIMA JOURNAL OF MEDICAL SCIENCE, 2019, 65 (03) : 71 - 75
  • [46] Gut microbiota and nonalcoholic fatty liver disease
    Machado, Mariana V.
    Cortez-Pinto, Helena
    [J]. ANNALS OF HEPATOLOGY, 2012, 11 (04) : 440 - 449
  • [47] Viral Liver Disease and Intestinal Gut-Liver Axis
    Kouroumalis, Elias
    Tsomidis, Ioannis
    Voumvouraki, Argyro
    [J]. GASTROINTESTINAL DISORDERS, 2024, 6 (01): : 64 - 93
  • [48] The gut-liver axis as a target of liver disease management
    Mandato, Claudia
    Bovi, Anna Pia Delli
    Vajro, Pietro
    [J]. HEPATOBILIARY SURGERY AND NUTRITION, 2021, 10 (01) : 100 - 102
  • [49] Gut-liver axis-mediated mechanism of liver cancer: A special focus on the role of gut microbiota
    Ohtani, Naoko
    Hara, Eiji
    [J]. CANCER SCIENCE, 2021, 112 (11) : 4433 - 4443
  • [50] Role of the Gut-Liver Axis in Liver Inflammation, Fibrosis, and Cancer: A Special Focus on the Gut Microbiota Relationship
    Ohtani, Naoko
    Kawada, Norifumi
    [J]. HEPATOLOGY COMMUNICATIONS, 2019, 3 (04) : 456 - 470